Cost Analysis of Outpatient Ophthalmic Procedures

Highlights

  • •

    Maximum intraoperative time is a novel framework to evaluate ambulatory surgical centers (ASCs).

  • •

    ASCs are well positioned to offer surgical procedures with low direct material cost.

  • •

    Inflation has a greater impact on ASCs than wage growth.

  • •

    Medicare facility reimbursement may be discussed to increase access to care at ASCs.

OBJECTIVE or PURPOSE

To evaluate the financial feasibility of various ophthalmic procedures performed at outpatient facilities, including ambulatory surgical centers (ASCs) and hospital outpatient departments (HOPDs), relative to Medicare facility reimbursement in 2025 and beyond.

DESIGN

Cost-efficiency analysis.

SUBJECTS, PARTICIPANTS, AND/OR CONTROLS

Outpatient facilities in San Diego, California.

METHODS, INTERVENTION, OR TESTING

In this study, we propose a novel framework to analyze ASCs and HOPDs based on the maximum intraoperative time to maintain financial neutrality. Common ophthalmic procedures were selected using insurance claims data. Total costs for each procedure were determined using a combination of internal financial records, defined operational frameworks, and publicly available data. These inputs were used to calculate the maximum intraoperative time for each procedure relative to the publicly available Medicare facility reimbursement rates.

MAIN OUTCOME MEASURES

The primary outcome was the total intraoperative time required to maintain financial neutrality for 9 common ophthalmic surgical procedures.

RESULTS

Common ophthalmic procedures included the following: cataract removal with insertion of intraocular lens, aqueous shunt to extraocular plate reservoir, upper eyelid blepharoplasty, dacryocystorhinostomy, trabeculectomy, penetrating keratoplasty, repair of blepharoptosis, strabismus repair, and mechanical pars plana vitrectomy. The maximum intraoperative time to maintain financial neutrality for ASCs ranged from 117.2 (aqueous shunt to extraocular equatorial plate reservoir) to 11.9 (vitrectomy) minutes and was driven by Medicare facility reimbursement and direct material cost per procedure. For HOPDs, the maximum intraoperative times were approximately twice as high for most procedures and ranged from 160.8 (aqueous shunt to extraocular equatorial plate reservoir; CPT 66180) to 54.5 (blepharoplasty, upper eyelid; CPT 15823) minutes.

CONCLUSIONS

In this analysis, most ophthalmic procedures performed at the ASCs analyzed had a maximum intraoperative time to maintain financial neutrality of >30 minutes, indicating that ASCs are well positioned to offer common ophthalmic surgical procedures in a financially efficient manner. Our model finds that Medicare reimbursement relative to the direct material cost per procedure was the main driver of maximum intraoperative time, highlighting the unique financial considerations ASCs may face due to limitations on reimbursement and lower Medicare facility fees compared with HOPDs. These findings support the utility of this framework in evaluating the cost-efficiency of ASCs to inform future decisions on procedures to adopt. Furthermore, our findings identify areas of discussion regarding the feasibility and utility of performing ophthalmic procedures at ASCs rather than in traditional hospital-based operating rooms to promote equitable access to health care.

INTRODUCTION

W ith increasing health care costs in the United States, care at outpatient centers, including hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs), has become more cost-effective than traditional hospital-based operating rooms. Although HOPDs are owned by and typically attached to larger hospitals, ASCs are typically standalone facilities that are often physician-owned and more specialized compared with HOPDs. ASCs, in particular, are becoming increasingly used due to a variety of factors, including increased surgeon productivity and lower overhead and operational expenses that translate to lower costs for patients and insurers. , As ASCs have grown in utilization, various measures have been defined to evaluate performance, including patient safety and reported outcomes, operating room turnover times and utilization, and case duration. Although these metrics can be used to evaluate the quality and efficiency of care provided by ASCs, cost-effectiveness remains poorly studied.

Ophthalmology has one of the highest utilizations of ASCs and HOPDs, with 95% of ophthalmic surgeries being performed in outpatient settings. Some studies estimate that upward of 60% of cataract surgeries are performed in ASCs, with utilization increasing year over year. In 2023, extracapsular cataract removal with intraocular lens insertion was the most common procedure among those performed in ASCs billed to Medicare. Utilization has increased across ophthalmic subspecialties as well, with the proportion of procedures performed in ASCs increasing across glaucoma, cornea, pediatrics, and retina. Outcomes and patient safety, as measured by rates of mortality and hospital admission, are similar between ASCs and hospitals, further incentivizing the transition toward ASCs in ophthalmology.

Despite trends toward increasing utilization of ASCs, formal cost reporting remains poor, which makes analyzing financial efficiency and cost-effectiveness challenging. One recent study evaluated vitrectomy costs and found that the costs of routine vitrectomy are significantly higher than standard reimbursement for academic institutions, highlighting the need for similar analyses in the setting of ASCs. As the Centers for Medicare Services (CMS) proposes changes that would alter ASC fee schedules and procedures they are permitted to perform, this study aimed to assess the financial feasibility of different ophthalmic procedures relative to current Medicare facility reimbursement for both ASCs and HOPDs. We analyzed the maximum intraoperative time needed to maintain cost neutrality across different ophthalmic surgical procedures and an adjusted model based on inflation rates and changes in reimbursements.

METHODS

In this cost-efficiency analysis, we propose a model that considers the operational and personnel costs of ASCs and HOPDs, the direct and indirect costs associated with individual procedures, and Medicare facility reimbursement to analyze the financial efficiency and cost-effectiveness of outpatient facilities. The output of this model is the maximum total intraoperative time to maintain financial neutrality, a unified time-based metric based on expenditure vs reimbursement. This metric allows for the evaluation and comparison of the financial efficiency of conducting various surgical procedures in the outpatient setting.

MEDICARE REIMBURSEMENT

We selected common surgical procedures performed across ophthalmic subspecialties using payor claims data. , We then determined Medicare ASC and HOPD facility fee schedules by Current Procedural Terminology (CPT) code using publicly available data for San Diego County (region 41740) ( Table 1 ). The CPT codes used were the following: 66984 (extracapsular cataract removal with insertion of intraocular lens prosthesis), 66180 (aqueous shunt to extraocular equatorial plate reservoir), 15823 (blepharoplasty, upper eyelid), 68720 (dacryocystorhinostomy), 66170 (fistulization of sclera for glaucoma; trabeculectomy ab externo in the absence of previous surgery), 65750 (keratoplasty; penetrating), 67904 (repair of blepharoptosis; (tarso) levator resection or advancement, external approach), 67312 (strabismus surgery, recession or resection procedure; 2 horizontal muscles), and 67036 (vitrectomy, mechanical, pars plana approach). Physician professional fees were not included in this analysis because they do not contribute to operational or material expenses associated with ASCs or HOPDs.

TABLE 1

Medicare Fee Schedule, Total Costs, and Maximum Intraoperative Time to Maintain Financial Neutrality by Procedure.

Procedure Description CPT Code Medicare Fee Schedule ($) Direct Material Cost ($) Indirect Material Cost ($/min) Total Cost/Minute ($/min) Maximum Intraoperative Time to Maintain Financial Neutrality (min)
Extracapsular cataract removal with insertion of intraocular lens prosthesis 66984 1359.42 380.23 0.42 30.50 32.1
Aqueous shunt to extraocular equatorial plate reservoir 66180 3833.01 270.81 0.32 30.40 117.2
Blepharoplasty, upper eyelid 15823 1098.33 175.99 0.03 30.11 30.6
Dacryocystorhinostomy 68720 1776.69 247.16 0.17 30.25 50.6
Fistulization of sclera for glaucoma; trabeculectomy 66170 1359.42 170.36 0.32 30.40 39.1
Keratoplasty; penetrating 65750 2942.43 388.55 0.32 30.40 84.0
Repair of blepharoptosis 67904 1148.61 225.83 0.03 30.11 30.6
Strabismus surgery; 2 horizontal muscles 67312 1776.69 196.67 0.02 30.11 52.5
Vitrectomy, mechanical, pars plana approach 67036 2344.60 1981.42 0.36 30.45 11.9*

*One-tailed t test, P <.05.

DETERMINATION OF COSTS

Costs for each procedure were divided into direct material costs and indirect costs ( Table 1 , Supplemental Tables 2-10). Direct material costs included disposable items used during individual procedures, including gloves, sutures, syringes, etc. (Supplemental Materials). Complete inventory and unit prices were determined using institutional financial records. Costs related to implants, grafts, and other discretionary supplies were excluded from analysis because total expense is more likely to vary per procedure based on patient need and physician clinical judgment. Furthermore, for frequently used implants, such as monofocal intraocular lenses, unit cost varies widely by facility due to the use of group purchasing agreements and other direct manufacturer negotiations. Indirect costs included expenses related to equipment used to perform each procedure, including phacoemulsification machines, operating room microscopes, electrocautery devices, and more (Supplemental Materials). We determined indirect costs of equipment by using retail prices from manufacturer websites. To calculate the proportion of indirect costs attributed to individual procedures, we assumed a 7-year lifetime , for each piece of equipment based on standard maintenance schedules, using it 5 days per week, excluding holidays. Any expenses that could be reimbursed directly under separate CPT codes were excluded.

DETERMINATION OF PERSONNEL COSTS

As this analysis focused exclusively on institutional procedural expenses for ASCs, we excluded personnel costs covered by Medicare professional or physician fees. The personnel costs that were included in our analysis were as follows: 1 scrub technician, 1 circulating nurse, 1 perioperative nurse, and 1 front desk coordinator. Annual compensation was determined using publicly available pay scales. All employees were assumed to work 5 days per week, excluding overtime, vacation, and holidays.

DETERMINATION OF OPERATIONAL COSTS

Operational costs for ASCs were determined based on the framework proposed by Childers and Maggard-Gibbons that analyzed financial disclosures from various types of hospitals in California to determine the cost of 1 minute of operating room time, adjusted for inflation to 2025 US dollars. In their analysis, they determined that total operating costs for ASCs consisted of direct costs (wages, benefits, supplies, and services related to maintenance) and indirect costs (costs not associated with departments, such as security). To estimate the total operational costs for the purposes of the present analysis, we included indirect costs and equipment maintenance expenses but excluded costs related to supplies and personnel because these were already accounted for. This figure was also used for the analysis of HOPDs because there was no significant difference found between the operational costs of ASCs and inpatient operating rooms associated with hospitals.

CALCULATION OF INTRAOPERATIVE TIME TO MAINTAIN FINANCIAL NEUTRALITY

A visual representation of the approach used to calculate the maximum total intraoperative time to maintain financial neutrality using the cost figures mentioned previously is illustrated in Figure 1 .

FIGURE 1

Visual representation of calculation to determine total intraoperative time to maintain financial neutrality for ASCs and HOPDs. ASC = ambulatory surgical center; HOPD = hospital outpatient department.

Our model also allowed us to evaluate the impact of inflation, wage growth, and changes in the Medicare fee schedule on the maximum intraoperative time to maintain financial neutrality ( Figure 2 ). We analyzed 2 scenarios based on current Consumer Price Index statistics: 3.00% inflation for 5 years (to 2030), 0.00% wage growth, and no change in Medicare fee schedules (scenario 1); and 0.00% inflation, 4.00% wage growth for 5 years (to 2030), and no change in Medicare fee schedules (scenario 2). In these 2 scenarios, we excluded the impact of inflation on indirect costs associated with each procedure, as these purchases are made infrequently due to the lifespan of equipment and therefore are not as affected by inflation.

FIGURE 2

Visual representation of adjustments applied to calculation of maximum intraoperative time to maintain financial neutrality to calculate impacts of inflation, wage growth, and changes in Medicare fee schedule.

We analyzed the maximum intraoperative time to maintain financial neutrality for individual procedures compared with the sample mean. A 1-tailed t test was used to compare individual times to assess whether they were significantly lower than average, defining α of <0.05 as statistically significant.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 19, 2026 | Posted by in OPHTHALMOLOGY | Comments Off on Cost Analysis of Outpatient Ophthalmic Procedures

Full access? Get Clinical Tree

Get Clinical Tree app for offline access